楊姝，副主任醫(yī)師，四川大學(xué)華西醫(yī)院臨床醫(yī)學(xué)博士

貴州省抗癌協(xié)會委員

西部放射治療協(xié)會婦科腫瘤專委會委員

從事腫瘤放化療治療10余年，先后在中國醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院、意大利ISTITUTO NAZIONALE TUMORI IRCCS-Fondazione Pascale針對腫瘤的放化療、免疫治療進(jìn)修學(xué)習(xí)。擅長婦科、消化系統(tǒng)等惡性腫瘤的診治。主持省級課題一項(xiàng)，發(fā)表SCI論文數(shù)篇。

相關(guān)文獻(xiàn)：

(1) Shu Yang; Qian Long; Min Chen; Xiao Liu; Hang Zhou ; CAF-1/p150 promotes cell proliferati on, migration, invasion and predicts a poor prognosis in patients with cervical cancer, Oncology Letters, 2020, 20(3): 2338-2346 (期刊論文)

 (2) Shu Yang; Hongying Zhang; Hua Yang; Jin Zhang; Yangfu Jiang; Hui Hua ; SEPHS1 promotes SM AD2/3/4 expression and hepatocellular carcinoma cells invasion, Experimental Hematology & Oncolog y, 2021, 10(17): 2162-3619 (期刊論文)

 (3) Shu Yang; Qihai Gong; Qin Wu; Fei Li; Yuanfu Lu; Jingshan Shi ; Alkaloids enriched extrac t from Dendrobium nobile Lindl. attenuates tau protein hyperphosphorylation and apoptosis induced by lipopolysaccharide in rat brain, PHYTOMEDICINE, 2014, 21(5): 712-716 (期刊論文)

(4) Yang, Songpeng; Yang, Shu; Zhang, Hongying; Hua, Hui; Kong, Qingbin; Wang, Jiao; Jiang, Y angfu ; Targeting Na+/K+-ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hep atocellular carcinoma, British Journal of Pharmacology, 2021, 178(21): 4389-4407 (期刊論文)